Literature DB >> 3662472

In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

M R Yeaman1, L A Mitscher, O G Baca.   

Abstract

Antibiotic susceptibility testing of the rickettsial Q fever agent Coxiella burnetii was performed by using persistently infected L929 fibroblast cells. The efficacies of a variety of antibiotics with different metabolic targets were tested and compared. The most effective antibiotics in bringing about the elimination of the parasite from infected cells included several quinolone compounds and rifampin. Of the quinolone compounds tested, difloxacin (A-56619) was the most effective, followed by ciprofloxacin and oxolinic acid. These three quinolones were apparently rickettsiacidal. After 48 h of exposure to microgram amounts of the compounds (ranging from 2 micrograms of difloxacin per ml to 5 micrograms of the other two antibiotics per ml), the number of intracellular parasites markedly declined; after 10 days of treatment, very few intracellular rickettsiae were detected. Rifampin (1 microgram/ml) was also very effective in eliminating the parasites. Some of the 13 other antibiotics tested that were somewhat effective included chloramphenicol, doxycycline, and trimethoprim. The persistently infected L929 cells were found to provide a convenient system for the relatively rapid determination of the susceptibility of C. burnetii to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3662472      PMCID: PMC174875          DOI: 10.1128/AAC.31.7.1079

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

2.  The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos.

Authors:  R A ORMSBEE; H PARKER; E G PICKENS
Journal:  J Infect Dis       Date:  1955 Mar-Apr       Impact factor: 5.226

3.  Q fever endocarditis in the south of France.

Authors:  D Raoult; J Etienne; P Massip; S Iaocono; M A Prince; P Beaurain; S Benichou; J C Auvergnat; P Mathieu; P Bachet
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

4.  A proposed model to explain persistent infection of host cells with Coxiella burnetii.

Authors:  M J Roman; P D Coriz; O G Baca
Journal:  J Gen Microbiol       Date:  1986-05

5.  Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii.

Authors:  E T Akporiaye; J D Rowatt; A A Aragon; O G Baca
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.

Authors:  O G Baca; E T Akporiaye; A S Aragon; I L Martinez; M V Robles; N L Warner
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Q fever endocarditis.

Authors:  M J Tobin; N Cahill; G Gearty; B Maurer; S Blake; K Daly; R Hone
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

8.  Chronic Q fever endocarditis.

Authors:  M P Varma; A A Adgey; J H Connolly
Journal:  Br Heart J       Date:  1980-06

9.  Q fever endocarditis.

Authors:  M A Pierce; M S Saag; W E Dismukes; C G Cobbs
Journal:  Am J Med Sci       Date:  1986-08       Impact factor: 2.378

10.  Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii.

Authors:  E T Akporiaye; O G Baca
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

View more
  39 in total

1.  Q fever in Quebec (1989-93): Report of 14 cases.

Authors:  M Goyette; A Poirier; J Bouchard; E Morrier
Journal:  Can J Infect Dis       Date:  1994-05

2.  Q fever meningoencephalitis in five patients.

Authors:  M Drancourt; D Raoult; B Xeridat; L Milandre; M Nesri; P Dano
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.

Authors:  D Raoult; H Torres; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; E Scoulica; A Psaroulaki; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.

Authors:  Robert E Brennan; James E Samuel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  A plasmid-encoded surface protein found in chronic-disease isolates of Coxiella burnetti.

Authors:  M F Minnick; R A Heinzen; D K Reschke; M E Frazier; L P Mallavia
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.

Authors:  D Raoult; M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.